Kyowa Hakko Kirin | 4151 - Ebitda


Kyowa Hakko Kirin reported JPY17.17B in EBITDA for its fiscal quarter ending in March of 2026.





Ebitda Change Date
Astellas Pharma JPY 98.93B 84.75B Mar/2026
Chugai Pharma JPY 158.77B 10.24B Mar/2026
Daiichi Sankyo JPY 101.6B 22.81B Mar/2025
Eisai JPY -335M 30.43B Mar/2026
Kyowa Hakko Kirin JPY 17.17B 28.58B Mar/2026
M3 JPY 15.05B 15.35B Mar/2026
Otsuka Holdings JPY 156.66B 56.89B Mar/2026
Shionogi JPY 28.75B 51.25B Mar/2026
Sumitomo Dainippon JPY 1.43B 78.97B Mar/2026
Takeda JPY 150.25B 297.88B Mar/2026
Terumo JPY 57.88B 12.1B Mar/2026